Advertisement
Increased exposure to steroids may be another driver of increased morbidity and mortality in this population
Gene variant holds key to those needing a different treatment
Explore best practices and future advances in primary vasculitides, April 5, 2017
AZA may be effective option when triple therapy fails
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement